Andrea Dickey is an Oncology physician. OpenAlex indexes 33 publications with 791 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1450 Chapel Street
New Haven, CT 06511
Telephone
203-867-5426Registry record last updated 28 Jan 2013.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
- AstraZeneca Pharmaceuticals LPProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
96.2%Aromatase Inhibitor71.4%Anastrozole74%Letrozole22%Exemestane4%Part D<11 patientsKinase inhibitor18.5%Ibrance86%Verzenio15%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.8%Serotonin-3 Receptor Antagonist3.8%Ondansetron Odt100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Structure of LRRK1 and mechanisms of autoinhibition and activation
Nature Structural & Molecular Biology
2023 - Western blot quantification dataset for Structure of LRRK1 and mechanisms of autoinhibition and activation
Zenodo (CERN European Organization for Nuclear Research)
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”